BackTevogen Bio Holdings - Warrants (14/02/2029) Overview
Tevogen Bio Holdings Inc. - Warrants (14/02/2029)

Tevogen Bio Holdings - Warrants (14/02/2029) Return on Equity

Tevogen Bio Holdings - Warrants (14/02/2029) (TVGNW) has a ROE of 243.15%, above the sector sector average of -5.71%.

Get informed when a big investor buys or sells

+ Follow

ROE

243.15%

Return on Equity

243.15%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Tevogen Bio Holdings - Warrants (14/02/2029) (TVGNW) FAQ

Tevogen Bio Holdings - Warrants (14/02/2029) posts a ROE of 243.15%. That is above the sector sector average of -5.71%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -5.71% is typical. Tevogen Bio Holdings - Warrants (14/02/2029)'s 243.15% is higher that level. That is roughly 4357.6% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Tevogen Bio Holdings - Warrants (14/02/2029)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 243.15%; use YoY and peer views to separate noise from signal.

Context for TVGNW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -5.71%), and (3) consistency with growth and profitability. This page covers the first two; Tevogen Bio Holdings - Warrants (14/02/2029)'s other metric pages and overview cover the third.